바이오서저리 시장 : 부문별 예측(2025-2030년)

The Biosurgery Market was valued at USD 15.13 billion in 2023, expected to reach USD 16.35 billion in 2024, and is projected to grow at a CAGR of 8.17%, to USD 26.22 billion by 2030.

The biosurgery market focuses on the development and application of biologically-originated surgical products, aiding in hemostasis, sealing, and tissue repair. This segment is critical for enhancing surgical outcomes, reducing operative risks, and accelerating recovery. Driven by an aging population, increasing surgical procedures, and technological advancements, the market is poised for growth, yet it faces challenges such as high costs and stringent regulatory scrutiny. Biosurgery finds applications in various surgeries, including orthopedic, cardiovascular, and neurosurgeries, with end-users being hospitals, clinics, and ambulatory surgical centers. Growth is predominantly fueled by an increasing focus on minimally invasive procedures, expansion in emerging markets, and improved healthcare infrastructure globally. Opportunities lie in the development of cost-effective and effective next-generation products, reflecting advances in biocompatible materials and regenerative medicine. However, market growth is hampered by pricing pressures, reimbursement issues, and a high capital investment requirement. A noteworthy limitation is the slow adoption in underdeveloped regions due to inadequate awareness and infrastructure. Emerging opportunities include innovations in tissue scaffolding, bioactive wound care products, and development of personalized medicine approaches leveraging biotechnological advancements. Companies can capitalize on these prospects by investing in R&D for enhanced biomaterials and leveraging strategic collaborations with research institutes to foster technological advancements. Additionally, expanding distribution networks in emerging economies where healthcare expenditure is rising can be a viable growth strategy. Fostering partnerships with healthcare providers to enhance product accessibility and affordability will play a crucial role. Staying adaptive to changing regulations and focusing on sustainable practices may further ensure resilience in a competitive landscape. Ultimately, the biosurgery market's nature is dynamic and highly competitive, with innovation and regulatory agility being keys to sustained success.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biosurgery Market

The Biosurgery Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising geriatric population and increase in the volume of minimal-invasive surgeries
  • Growing need for effective blood loss management in patients
  • Increase in investments by the government in the biosurgery
• Market Restraints
  • Concern associated with high cost of biosurgery
• Market Opportunities
  • Introduction of advanced and tech-driven biosurgery products
  • Potential development of medical tourism and rise in need for advanced bio materials
• Market Challenges
  • Stringent regulatory framework and dearth of clinical expertise

Porter's Five Forces: A Strategic Tool for Navigating the Biosurgery Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biosurgery Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biosurgery Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biosurgery Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biosurgery Market

A detailed market share analysis in the Biosurgery Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biosurgery Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biosurgery Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biosurgery Market

A strategic analysis of the Biosurgery Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biosurgery Market, highlighting leading vendors and their innovative profiles. These include Aroa Biosurgery Limited, Artivion, Inc., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson, and Company, Boston Scientific Corporation, Cabaletta Bio, Inc., CSL Limited, Getinge AB, Hemostasis, LLC, Integra LifeSciences Corporation, Johnson & Johnson Services Inc., Kuros Bioscience AG, Medtronic PLC, Ocular Therapeutix, Inc., Orthofix Medical, Inc., Pfizer Inc., RTI Surgical, Inc., Samyang Holdings Corporation, Sanofi SA, Smith & Nephew plc, Stryker Corporation, Tissue Regenix Ltd, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Biosurgery Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Adhesion Barriers, Bone Graft Attachments, Hemostatic Agents, Soft Tissue Attachments, and Surgical Sealants.
• Based on Source, market is studied across Biologics Products and Synthetic Products.
• Based on Application, market is studied across Cardiovascular Surgery, General Surgery, Gynecology Surgery, Neurological Surgery, Orthopedic Surgery, Thoracic Surgery, and Urology Surgery.
• Based on End-Users, market is studied across Clinics and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising geriatric population and increase in the volume of minimal-invasive surgeries
    • 5.1.1.2. Growing need for effective blood loss management in patients
    • 5.1.1.3. Increase in investments by the government in the biosurgery
  • 5.1.2. Restraints
    • 5.1.2.1. Concern associated with high cost of biosurgery
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of advanced and tech-driven biosurgery products
    • 5.1.3.2. Potential development of medical tourism and rise in need for advanced bio materials
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory framework and dearth of clinical expertise
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biosurgery Market, by Product

• 6.1. Introduction
• 6.2. Adhesion Barriers
• 6.3. Bone Graft Attachments
• 6.4. Hemostatic Agents
• 6.5. Soft Tissue Attachments
• 6.6. Surgical Sealants

7. Biosurgery Market, by Source

• 7.1. Introduction
• 7.2. Biologics Products
• 7.3. Synthetic Products

8. Biosurgery Market, by Application

• 8.1. Introduction
• 8.2. Cardiovascular Surgery
• 8.3. General Surgery
• 8.4. Gynecology Surgery
• 8.5. Neurological Surgery
• 8.6. Orthopedic Surgery
• 8.7. Thoracic Surgery
• 8.8. Urology Surgery

9. Biosurgery Market, by End-Users

• 9.1. Introduction
• 9.2. Clinics
• 9.3. Hospitals

10. Americas Biosurgery Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Biosurgery Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Biosurgery Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Aroa Biosurgery Limited
• 2. Artivion, Inc.
• 3. B. Braun Melsungen AG
• 4. Baxter International Inc.
• 5. Becton, Dickinson, and Company
• 6. Boston Scientific Corporation
• 7. Cabaletta Bio, Inc.
• 8. CSL Limited
• 9. Getinge AB
• 10. Hemostasis, LLC
• 11. Integra LifeSciences Corporation
• 12. Johnson & Johnson Services Inc.
• 13. Kuros Bioscience AG
• 14. Medtronic PLC
• 15. Ocular Therapeutix, Inc.
• 16. Orthofix Medical, Inc.
• 17. Pfizer Inc.
• 18. RTI Surgical, Inc.
• 19. Samyang Holdings Corporation
• 20. Sanofi SA
• 21. Smith & Nephew plc
• 22. Stryker Corporation
• 23. Tissue Regenix Ltd
• 24. Zimmer Biomet Holdings, Inc.